Vertex Pharmaceuticals IncorporatedStock Price and Value Analysis

Should you buy Vertex Pharmaceuticals Incorporated stock? (NasdaqGS:VRTX). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
None.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company is not making money.
  • This company pays no dividend.

VRTX Free Cash Flow Trend

Hmm, we can't give any reliable projection for Vertex Pharmaceuticals Incorporated's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for VRTX
Free Cash Flow trendline for Vertex Pharmaceuticals Incorporated

Inside the VRTX Numbers

VRTX Price
(Vertex Pharmaceuticals Incorporated stock price per share)
$143.61
[?] PE Ratio versus Sector 813% higher than other Healthcare stocks
[?] PE Ratio versus Industry 220% higher than other Biotechnology stocks
[?] Cash Yield -1.18%
[?] Free Cash Flow Jitter 120%

Is Vertex Pharmaceuticals Incorporated Stock on Sale?

Based on our analysis, we believe that you should not buy Vertex Pharmaceuticals Incorporated right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy VRTX Stock?

Does Vertex Pharmaceuticals Incorporated have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.